Back to search
🇺🇸

United States · US · US:0002-4491_75a13e98-3736-4256-8277-6c05bcaddcf5

Reyvow

In shortageOrange BookUNIISPLATC N02CC08

Last synced from FDA National Drug Code directory (United States) on

Identification

ManufacturerEli Lilly and Company
CountryUS (United States)
ATC codeN02CC08
Dispensing
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026

Packs · 3

  • ndc11
    0002449108
    2 BLISTER PACK in 1 CARTON (0002-4491-08) / 4 TABLET in 1 BLISTER PACK
  • ndc11
    0002449161
    1 BLISTER PACK in 1 CARTON (0002-4491-61) / 4 TABLET in 1 BLISTER PACK
  • ndc11
    0002449162
    1 BLISTER PACK in 1 CARTON (0002-4491-62) / 2 TABLET in 1 BLISTER PACK

Annotations

UNII (FDA Substance ID)
760I9WM792
LASMIDITAN
RxCUI 2256930
Orange Book
N211280
DailyMed SPL labels
1 version tracked
FDA shortage
Currently in shortage
Lasmiditan Succinate Tablet
Raw payload (JSON)
{
  "unii": {
    "unii": "760I9WM792",
    "rxcui": "2256930",
    "inchikey": "XEDHVZKDSYZQBF-UHFFFAOYSA-N",
    "display_name": "LASMIDITAN",
    "substance_type": "chemical",
    "ingredient_type": "INGREDIENT SUBSTANCE"
  },
  "route": "ORAL",
  "spl_meta": {
    "aea3358c-ff41-4490-9e6d-c7bf7b3de13f": {
      "match": "brand_token",
      "title": "REYVOW (LASMIDITAN) TABLET [ELI LILLY AND COMPANY]",
      "spl_version": "15",
      "published_date": "2024-12-16"
    }
  },
  "productid": "0002-4491_75a13e98-3736-4256-8277-6c05bcaddcf5",
  "productndc": "0002-4491",
  "dosage_form": "TABLET",
  "orange_book": {
    "appl_no": "211280",
    "products": [
      {
        "rs": false,
        "rld": true,
        "te_code": null,
        "strength": "EQ 50MG BASE",
        "product_no": "001",
        "approval_date": "Jan 31, 2020"
      },
      {
        "rs": true,
        "rld": true,
        "te_code": null,
        "strength": "EQ 100MG BASE",
        "product_no": "002",
        "approval_date": "Jan 31, 2020"
      },
      {
        "rs": false,
        "rld": true,
        "te_code": null,
        "strength": "EQ 200MG BASE",
        "product_no": "003",
        "approval_date": "Dec 18, 2020"
      }
    ],
    "appl_type": "N"
  },
  "dea_schedule": "CV",
  "product_type": "HUMAN PRESCRIPTION DRUG",
  "substance_name": "LASMIDITAN",
  "shortage_reason": "Lasmiditan Succinate Tablet",
  "shortage_status": "current",
  "proprietary_name": "Reyvow",
  "active_ingred_unit": "mg/1",
  "application_number": "NDA211280",
  "marketing_category": "NDA",
  "nonproprietary_name": "lasmiditan",
  "start_marketing_date": "20191011",
  "active_numerator_strength": "100"
}

Related drugs

Other records sharing ATC code N02CC08.

Access this data programmatically

Query Reyvow and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.